SLYND is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Exeltis Usa, Inc.. The primary component is Drospirenone.
| Product ID | 0642-7470_0cdabfc8-f647-42d8-bd85-da6e8a875f24 |
| NDC | 0642-7470 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SLYND |
| Generic Name | Drospirenone |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-06-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA211367 |
| Labeler Name | Exeltis USA, Inc. |
| Substance Name | DROSPIRENONE |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-09-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA211367 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-09-01 |
| Marketing Category | NDA |
| Application Number | NDA211367 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-09-01 |
| Marketing Category | NDA |
| Application Number | NDA211367 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-06-06 |
| Marketing Category | NDA |
| Application Number | NDA211367 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-09-01 |
| Ingredient | Strength |
|---|---|
| DROSPIRENONE | 4 mg/1 |
| SPL SET ID: | db32bc55-f295-4d87-9dbb-0a2f45573dcf |
| Manufacturer | |
| UNII |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SLYND 88802490 not registered Live/Pending |
Chemo Research, S.L. 2020-02-19 |
![]() SLYND 88274384 not registered Live/Pending |
CHEMO RESEARCH, S.L. 2019-01-24 |